Adeleke varsity VC claims COVID-19 vaccine developed by Nigerian scientists is at clinical trial stage
The Vice Chancellor of Adeleke University, Prof. Solomon Adebiola, has said that the COVID-19 vaccine developed by a lecturer in the university, Prof. Oladipo Kolawole, in collaboration with others from five other universities in the country is currently at the clinical trial stage.
He claimed that it was recognised by the World Health Organisation (WHO) and supported by the Federal Ministry of Health.
He said the breakthrough by the Nigerian scientists had added to the myriad of achievements being showcased by the school management to mark its 10 years of existence.
Adebola said the vaccine was one of the two from Africa and the only one from Nigeria, which was recognised by WHO.
He said the second one from Africa came from scientists in Egypt.
He said: ‘’Currently, the vaccine is at clinical trial stage where we are experimenting with animal before it moves to human trial.
Besides, the Team’s Deputy Co-ordinator, Prof. Olubukola Oyawoye, a lecturer at Adeleke university, said the vaccine meets the international requirement, pointing out that its ribonucleic acid separation was conducted at a molecular laboratory in the United States (U.S.)
On the university’s achievements within a decade, the Vice Chancellor said it had graduated 1,863 students since inception in 2015 while its 30 courses across six faculties were fully accredited by the Nigeria Universities Commission (NUC).